CN105310078A - 粒状可溶的葡聚糖制备 - Google Patents
粒状可溶的葡聚糖制备 Download PDFInfo
- Publication number
- CN105310078A CN105310078A CN201510666215.1A CN201510666215A CN105310078A CN 105310078 A CN105310078 A CN 105310078A CN 201510666215 A CN201510666215 A CN 201510666215A CN 105310078 A CN105310078 A CN 105310078A
- Authority
- CN
- China
- Prior art keywords
- granular
- beta glucan
- solvable
- composition
- glucan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001503 Glucan Polymers 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title description 4
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 52
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 52
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 235000013361 beverage Nutrition 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 description 18
- 238000000034 method Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 5
- 229920002307 Dextran Polymers 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 240000005979 Hordeum vulgare Species 0.000 description 2
- 235000007340 Hordeum vulgare Nutrition 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011210 chromatographic step Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 238000002715 modification method Methods 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000131971 Bradyrhizobiaceae Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101001105486 Homo sapiens Proteasome subunit alpha type-7 Proteins 0.000 description 1
- 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 102100021201 Proteasome subunit alpha type-7 Human genes 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 108700012920 TNF Proteins 0.000 description 1
- 102100039390 Toll-like receptor 7 Human genes 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000013501 data transformation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
- A23L29/271—Curdlan; beta-1-3 glucan; Polysaccharides produced by agrobacterium or alcaligenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/22—Agglomeration or granulation with pulverisation of solid particles, e.g. in a free-falling curtain
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/04—Disaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/502—Gums
- A23V2250/5034—Beta-Glucan
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Fodder In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
粒状β-葡聚糖在提高的压力和温度下溶解以形成粒状可溶的β-葡聚糖。粒状可溶的β-葡聚糖能够被干燥成粉末形式且随后再溶解。
Description
本申请是申请日2008年5月8日、申请号200880014957.4、发明名称“粒状可溶的葡聚糖制备”的中国专利申请的分案申请。
技术领域
本发明涉及一种粒状可溶的β-葡聚糖。更具体而言,本发明涉及一种改良方法和粒状可溶的β-葡聚糖的组合物。
背景技术
本申请要求2007年5月8日申请的,发明名称为“可溶葡聚糖制备”的U.S.临时申请No.60/916,690的权益。
葡聚糖通常描述为葡萄糖的聚合物且来源于酵母、细菌、真菌和植物例如燕麦和大麦。已知含β(1-3)-连接的吡喃葡萄糖主链的葡聚糖具有生物活性,特别是,它们表现出调控免疫系统,并且近来表现出诱导造血干细胞和祖细胞(HSPC)活动。
之前,生产高质量的可溶β-葡聚糖很昂贵。例如,昂贵的成本抑制其作为营养增补剂或食品成分。因此,需要一种改良的可溶β-葡聚糖。
发明内容
本发明涉及一种粒状可溶的β-葡聚糖。更具体而言,本发明涉及一种改良方法和粒状可溶的β-葡聚糖的组合物。粒状β-葡聚糖在升高的温度和压力下溶解在酸性溶液中。采用例如离心和/或色谱技术可将制得的可溶β-葡聚糖进一步澄清和纯化。制得的产品甚至在还含有高分子量葡聚糖时也可干燥成粉末且随后再溶解。
附图说明
图1-4是粒状可溶的β-葡聚糖样品的RI踪迹和数据转化图。
图5是各种β-葡聚糖诱导TNFa的生产的示意图。
具体实施方式
本发明所用的起始材料是由任何方法制备的粒状,或不可溶的β-葡聚糖。粒状β-葡聚糖起始材料的大小范围可从整个(whole)葡聚糖颗粒小至亚微米大小的颗粒。起始材料中的杂质水平也可变化。但是,随着起始材料中杂质水平的增加,回收的可溶葡聚糖数量会降低。适宜作为起始材料的一个例子是来自Biothera的WGP
许多来源的任意b-葡聚糖都可用于本发明。这些来源的例子为酵母、大麦、燕麦、蘑菇和其他真菌等。
在压力和提高温度下以酸处理粒状β-葡聚糖以产生可溶β-葡聚糖。开始时,将丸化的、粒状β-葡聚糖在缓冲液中再悬浮并混合于可密封反应容器中且调至pH3.6。加入缓冲试剂以使每升总体积的最终悬浮混合物含有约0.61g乙酸钠,5.24ml冰醋酸和430g丸化的,粒状β-葡聚糖。容器经氮气吹扫以去除氧气并增加反应容器内的压力。
通常地,将容器内部压力调至35PSI,将悬浮液加热至约135℃至多约5.5小时。发现在这样的条件下β-葡聚糖将溶解。随着温度从135℃下降,溶解量也下降。
应该注意的是这个温度和压力仅对上述实施方式是最优的。如果反应条件和/或试剂有任何改变则可能需要优化和调整温度和压力。
增加的压力和温度,通过实质上在工艺中消除使用有害化学物质,使其相对于现有技术中溶解β-葡聚糖的工艺具有优势。之前所用的有害化学物质包括例如可燃的VOC例如醚和乙醇,极强酸例如甲酸和硫酸和极高pH的苛性碱溶液。本工艺不仅更安全,而且通过减少所用的不同化学物质的量和所涉及的步骤数量,更为经济。
本工艺的另一个优势是上述处理的长度控制制得的粒状可溶的β-葡聚糖分子量。如全文所用的术语,“粒状可溶的β-葡聚糖”可以是任何可溶的,粒状状或再溶解形式。处理时间长度与制得的分子量大小负相关。换而言之,随着处理时间的增长,制得的粒状可溶的β-葡聚糖的平均分子量降低。该原理如下文所示。
在上述工艺期间的多个时间点(60,90,120和240分钟),从一批粒状可溶的β-葡聚糖悬浮液中收集四个样品。通过尺寸排阻色谱对比右旋糖苷分子量标记测定样品的分子量。结果如表1所汇总。
表1
取样时间 | Mn* | Mw** | Mz*** | 己糖浓度 |
60分钟 | 5,500 | 352,000 | 4,250,000 | 5.16mg/mL |
90分钟 | 8,500 | 1,180,000 | 5,430,000 | 12.33mg/mL |
120分钟 | 6,600 | 354,000 | 2,730,000 | 11.26mg/mL |
240分钟 | 5,100 | 56,500 | 362,000 | ≈25mg/mL |
*由计算的数均分子量
**由计算的重均分子量
其中Ni是分子量Mi的分子数量
***z-平均分子量,其是基于聚合物链的体积。
由上述数据可证明,在约90分钟时最大平均尺寸的粒状β-葡聚糖慢慢开始发生降解。90分钟的时间点之后,平均尺寸减小。时间点的特定数据如图1-4所示。
图1包括了组A和B。组A是60分钟样品的折射率(RI)踪迹描述。组B中,将组A中产生的数据部分转化并点绘在所示图表中。曲线10表示转化的原始数据。曲线12表示特定分子量的累计百分率。通过由已知大小的右旋糖苷生成的标准曲线测定分子量(数据未显示)。
90分钟样品生成的数据如图2所示。具有曲线14和16的组A和组B,对应图1的组A和组B。
120分钟样品生成的数据如图3所示。具有曲线18和20的组A和组B对应图1的组A和组B。
240分钟样品生成的数据如图4所示。具有曲线22和24的组A和组B对应图1的组A和组B。
特定大小的粒状可溶的葡聚糖可更适用于特定用途。例如,当局部应用时,较小分子量的分子可更好地渗透皮肤。另一方面,更大分子量分子可更好地适宜口服施用。因此,易于控制葡聚糖分子平均大小的能力提供了明显有竞争力的优势。
通过采样反应器内容物而实验性地测定热处理精确时间。可实施各种试验例如凝胶渗透色谱(GPC)分析法。该工艺可使符合特定规格特性和杂质水平的粒状可溶的材料的收率最大化。一旦β-葡聚糖被溶解,则冷却混合物以终止反应。
可在该点清洗和利用粒状可溶的β-葡聚糖,但是,对于药物用途则通常要进行进一步纯化。可采用以下步骤中的一个或多个的任意组合以进一步纯化和/或澄清粒状可溶的β-葡聚糖。如有需要也可采用本领域已知的其他手段。适宜的手段包括例如离心或连续流离心,其消除了大量的脂质杂质。
在一些情况中,粒状可溶的β-葡聚糖内部的脂质包含体可增强其对某些传染病的效力或增强免疫系统的效力。此处所述的工艺提供一种有效控制和改变粒状可溶的β-葡聚糖组合物中脂质数量的方式。
可选地或额外地,可过滤粒状可溶的β-葡聚糖。在一个实施方式中,以0.2μm的过滤器过滤材料。
也可采用色谱进行纯化。粒状可溶的β-葡聚糖可在制备中的某些点针对色谱进行调节。例如,若色谱步骤包括疏水作用色谱(HIC),可以硫酸铵和醋酸钠溶液将粒状可溶的β-葡聚糖调节为适宜的传导率和pH。适宜溶液是3.0M硫酸铵,0.1M醋酸钠,其被用于将pH调整至5.5。
可利用的其他色谱步骤是凝胶渗透色谱(GPC)。可能需要多重色谱循环以确保负载不超出柱容量。
在该点上,将粒状可溶的β-葡聚糖纯化备用。通常收集的粒状可溶的β-葡聚糖具有>1,000,000Da的平均分子量和高多分散性。这种粒状可溶的β-葡聚糖产品特别是高分子量范围如超过1000000道尔顿(Da)的优势在于产品可被喷雾干燥成粉末形式然后在pH约5和更高尤其是弱酸至强碱的溶液中随后再溶解。此外,再溶解发生在低至约室温的温度下(~25℃)。依据再溶解之后的最终浓度和所用溶剂,再溶解的时间和温度要求会变化。
产品再溶解的能力使其可理想地生成适宜于例如速溶饮料粉末的速食形式的β-葡聚糖。简言之,干燥形式的粒状可溶的β-葡聚糖被再润湿以达到约9-12%的水分含量,其形成团聚体。通过双流体喷嘴将表面活性剂例如卵磷脂添加到团聚体中。依据所用表面活性剂和条件和将最终溶解产品的溶剂而改变表面活性剂的浓度。然后将团聚物通过流化床干燥器的三个阶段。第一阶段加热产品,第二阶段调节产品而第三阶段冷却产品。制得的产品筛分后形成速食产品。
形成速食产品的另一方式是通过添加第二干燥形式可溶成分例如蔗糖或食盐(NaCl)。在一个实施例中,200mg粉末状的,粒状可溶的β-葡聚糖和约0.5-约1.0g蔗糖晶体被混入并在mortor碗中研磨约2-3分钟。该混合物加入500ml室温水并剧烈摇晃。粒状可溶的β-葡聚糖再溶解。以NaCl进行相同实验得到一致的结果。
粒状可溶的β-葡聚糖产品,不论是以其溶解,粉末或再溶解形式,都可用于许多用途。粒状可溶的β-葡聚糖理想地用作人和农业/伴侣/外来动物的营养增补剂,食品成分,化妆品成分和药物产品。
可添加的干燥或润湿形式的粒状可溶的β-葡聚糖的典型食物包括例如谷物和谷物产品,焙烤商品和烘焙混合物,饮料和饮料基料,乳制品类似物例如豆乳,乳和乳产品,植物蛋白产品,加工水果和果汁,软糖,汤和汤混合物,酸奶,瓶装水和饮料,营养棒等。如果需要可添加多种掩蔽剂和其他添加剂以改善风味和质地。
以其液体形式,粒状可溶的β-葡聚糖可用于制备可食膜。通过任何本领域已知的很多手段可干燥液体产品薄层。可在液体产品中添加添加剂以形成多种质地的膜或使它们或多或少的柔韧。膜可用作药物或补充产品的载体。此处同样,可添加多种掩蔽剂以改善膜的风味。
粒状可溶的β-葡聚糖与现有技术的粒状β-葡聚糖相比也更有效。例如,该产品可对传染病或癌症更有效。效力增强可以是在吸收更好,更好的免疫系统增强,给药方案减少等方面。
为此,体外研究显示高达300μg/mL浓度的粒状可溶的β-葡聚糖不会由人类外周血单核细胞(PBMC)诱导TNFα。特别是,在含5%热灭活的FCS的cRPMI培养基中培养人PBMC。以各种β-葡聚糖(所有都不含内毒素),TLR7/8激动剂,或媒介刺激细胞。使用各种浓度的β-葡聚糖。在5%CO2,37℃下过夜培育后,收集无细胞上清液,并在-20℃储存直至以ELISA进行细胞因子分析。图5中显示了三次重复的结果。如图所证明,整个(whole)葡聚糖颗粒刺激了TNFα的产生,而粒状可溶的产品则不会。因为TNFα是参与炎症反应的主要细胞因子,所以预期粒状可溶的产品不会诱导炎症反应。
尽管参照特定实施方式表现和描述本发明,本领域技术人员会理解可以在形式和细节上进行多种改变而不会使其偏离所附权利要求涵盖的本发明的精神和范围。
Claims (10)
1.组合物,含有粒状可溶的β-葡聚糖,其来源于酵母并且具有至少11的多分散性指数,并且能够被干燥成粉末形式且然后在pH为5或更高的溶液中被再溶解。
2.如权利要求1所述的组合物,进一步含有:第二干燥形式的可溶成分。
3.如权利要求1所述的组合物,其中该溶液的温度是25℃。
4.如权利要求1所述的组合物,其中该溶液是供人和/或动物消耗的饮料。
5.组合物,含有粒状可溶的β-葡聚糖,其来源于酵母并且具有至少11的多分散性指数,并且能够被干燥成粉末形式且然后在25℃的溶液中被再溶解。
6.如权利要求5所述的组合物,其中粒状可溶的b-葡聚糖具有55,000Da至1,000,000Da的平均分子量。
7.如权利要求5所述的组合物,其中该溶液是供人和/或动物消耗的饮料。
8.组合物,含有粒状可溶的β-葡聚糖,其来源于酵母并且具有至少11的多分散性指数,该组合物是液体或干燥形式,干燥形式能够在pH为5或更高的液体中再溶解。
9.权利要求8的组合物,其中粒状可溶的β-葡聚糖具有55,000Da至1,000,000Da的平均分子量。
10.权利要求8所述的组合物,其中该溶液的温度是25℃。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91669007P | 2007-05-08 | 2007-05-08 | |
US60/916690 | 2007-05-08 | ||
CN200880014957.4A CN101711112B (zh) | 2007-05-08 | 2008-05-08 | 粒状可溶的葡聚糖制备 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880014957.4A Division CN101711112B (zh) | 2007-05-08 | 2008-05-08 | 粒状可溶的葡聚糖制备 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105310078A true CN105310078A (zh) | 2016-02-10 |
CN105310078B CN105310078B (zh) | 2018-03-30 |
Family
ID=40002543
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880014957.4A Active CN101711112B (zh) | 2007-05-08 | 2008-05-08 | 粒状可溶的葡聚糖制备 |
CN201510666215.1A Active CN105310078B (zh) | 2007-05-08 | 2008-05-08 | 粒状可溶的葡聚糖制备 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880014957.4A Active CN101711112B (zh) | 2007-05-08 | 2008-05-08 | 粒状可溶的葡聚糖制备 |
Country Status (13)
Country | Link |
---|---|
US (3) | US7981447B2 (zh) |
EP (1) | EP2155000A4 (zh) |
JP (3) | JP5562837B2 (zh) |
KR (2) | KR101547970B1 (zh) |
CN (2) | CN101711112B (zh) |
AU (1) | AU2008251847B2 (zh) |
BR (1) | BRPI0811274A2 (zh) |
CA (1) | CA2690918C (zh) |
CO (1) | CO6251216A2 (zh) |
MX (1) | MX2009012070A (zh) |
MY (1) | MY150220A (zh) |
UA (1) | UA101617C2 (zh) |
WO (1) | WO2008140744A1 (zh) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2032180B1 (en) | 2006-06-15 | 2017-03-15 | Biothera, Inc. | Glucan preparations |
CN101711112B (zh) * | 2007-05-08 | 2015-11-25 | 生物高聚物工程公司Dba生物治疗公司 | 粒状可溶的葡聚糖制备 |
FI20070993A0 (fi) * | 2007-12-19 | 2007-12-19 | Valtion Teknillinen | Menetelmä beta-glukaanin käsittelemiseksi |
WO2012154818A1 (en) | 2011-05-09 | 2012-11-15 | Biothera, Inc. | B-glucan compounds, compositions, and methods |
ES2869181T3 (es) | 2011-06-03 | 2021-10-25 | Hibercell Inc | Métodos y preparaciones de beta-glucano opsonizado |
BR112014020543A8 (pt) | 2012-02-22 | 2018-01-23 | Algal Scient Corporation | composições de ração e métodos de utilização das mesmas |
WO2013165593A1 (en) | 2012-04-30 | 2013-11-07 | Biothera, Inc. | COMPOSITIONS AND METHODS FOR β-GLUCAN IMMUNOTHERAPY |
CN106133130A (zh) * | 2013-11-05 | 2016-11-16 | 生物治疗公司 | 降低葡聚糖的异味产生的方法 |
EP3077816B1 (en) | 2013-12-05 | 2021-03-24 | Biothera, Inc. | Beta-glucan assay methods |
WO2016007876A1 (en) | 2014-07-10 | 2016-01-14 | Biothera, Inc. | Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironment |
CN107106593B (zh) | 2014-11-06 | 2021-05-07 | 百奥赛诺公司 | 影响肿瘤微环境的β-葡聚糖方法与组合物 |
EP3436544A4 (en) * | 2016-03-28 | 2019-07-10 | Cargill, Incorporated | SOLUBLE AND FILTRABLE BIOPOLYMER SOLIDS |
US9901606B2 (en) | 2016-06-09 | 2018-02-27 | Algaeon, Inc. | Euglena lysate composition |
WO2018156888A1 (en) | 2017-02-24 | 2018-08-30 | Biothera Pharmaceuticals, Inc. | Beta glucan immunopharmacodynamics |
EP3792230A1 (en) * | 2019-09-11 | 2021-03-17 | Clariant Produkte (Deutschland) GmbH | Biopolymer cement additive |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5322841A (en) * | 1989-09-08 | 1994-06-21 | Alpha-Beta Technology, Inc. | Method for producing neutral glucans for pharmaceutical applications |
CN1235552A (zh) * | 1996-09-25 | 1999-11-17 | 格雷斯林克有限公司 | β-葡聚糖产物及从谷物中提取的方法 |
US6369216B1 (en) * | 1998-09-25 | 2002-04-09 | Biopolymer Engineering Pharmaceutical, Inc. | Very high molecular weight β-glucans |
US20040082539A1 (en) * | 1995-03-13 | 2004-04-29 | Novogen Research Party, Ltd. | Novel therapeutic uses of glucan |
WO2004061115A1 (ja) * | 2002-12-27 | 2004-07-22 | Immudyne Japan Inc. | 免疫機能を有する可溶性β−グルカンの製造方法及び用途 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811542A (en) * | 1989-09-08 | 1998-09-22 | Alpha-Beta Technology, Inc. | Method for producing soluble glucans |
US5622939A (en) * | 1992-08-21 | 1997-04-22 | Alpha-Beta Technology, Inc. | Glucan preparation |
NO300692B1 (no) * | 1994-04-29 | 1997-07-07 | Biotec Mackzymal As | Solubilisert forgrenet ß-1,3-glukan og anvendelse derav samt anvendelse av usolubilisert forgrenet ß-1,3-glukan |
DE19860371A1 (de) * | 1998-12-28 | 2000-06-29 | Aventis Res & Tech Gmbh & Co | Kosmetische oder medizinische Zubereitung für die topische Anwendung |
US6485945B1 (en) | 1999-02-17 | 2002-11-26 | Nurture, Inc. | Polysaccharide compositions and uses thereof |
US6323338B1 (en) * | 1999-02-17 | 2001-11-27 | Nurture, Inc. | Method for concentrating β-glucan |
US20040023923A1 (en) * | 2000-07-03 | 2004-02-05 | Morgan Keith Raymond | Cold water soluble beta-glucan product and process for preparing the same |
JP2002105101A (ja) * | 2000-10-03 | 2002-04-10 | Ajinomoto Co Inc | 水溶性高分子の製造法 |
AU2002233639B2 (en) * | 2001-02-15 | 2007-03-01 | Adeka Corporation | Products containing $G(b)-glucan |
US7923437B2 (en) * | 2001-02-16 | 2011-04-12 | Cargill, Incorporated | Water soluble β-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same |
US20060122149A1 (en) * | 2003-05-02 | 2006-06-08 | Ceapro Inc. | Extraction and purification method for cereal beta-glucan |
FI20040804A (fi) * | 2004-06-11 | 2005-12-12 | Glubikan Ab Oy | Menetelmä viljan ainesosan erottamiseksi |
US20090047288A1 (en) * | 2006-06-15 | 2009-02-19 | Jun Yan | Glucan compositions and methods of enhancing CR3 dependent neutrophil-mediated cytotoxicity |
CN101711112B (zh) * | 2007-05-08 | 2015-11-25 | 生物高聚物工程公司Dba生物治疗公司 | 粒状可溶的葡聚糖制备 |
-
2008
- 2008-05-08 CN CN200880014957.4A patent/CN101711112B/zh active Active
- 2008-05-08 US US12/151,666 patent/US7981447B2/en active Active
- 2008-05-08 JP JP2010507462A patent/JP5562837B2/ja active Active
- 2008-05-08 WO PCT/US2008/005914 patent/WO2008140744A1/en active Application Filing
- 2008-05-08 MX MX2009012070A patent/MX2009012070A/es active IP Right Grant
- 2008-05-08 KR KR1020097025513A patent/KR101547970B1/ko active IP Right Grant
- 2008-05-08 MY MYPI20094702A patent/MY150220A/en unknown
- 2008-05-08 EP EP08754267.6A patent/EP2155000A4/en active Pending
- 2008-05-08 BR BRPI0811274-6A2A patent/BRPI0811274A2/pt not_active Application Discontinuation
- 2008-05-08 UA UAA200912721A patent/UA101617C2/ru unknown
- 2008-05-08 AU AU2008251847A patent/AU2008251847B2/en active Active
- 2008-05-08 KR KR1020147023009A patent/KR101665216B1/ko active IP Right Grant
- 2008-05-08 CA CA2690918A patent/CA2690918C/en active Active
- 2008-05-08 CN CN201510666215.1A patent/CN105310078B/zh active Active
-
2009
- 2009-12-04 CO CO09138987A patent/CO6251216A2/es not_active Application Discontinuation
-
2011
- 2011-07-11 US US13/180,290 patent/US8530642B2/en active Active
-
2013
- 2013-04-24 US US13/869,531 patent/US8859759B2/en active Active
-
2014
- 2014-06-11 JP JP2014120772A patent/JP6007209B2/ja active Active
-
2016
- 2016-07-14 JP JP2016139505A patent/JP2016198108A/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5322841A (en) * | 1989-09-08 | 1994-06-21 | Alpha-Beta Technology, Inc. | Method for producing neutral glucans for pharmaceutical applications |
US20040082539A1 (en) * | 1995-03-13 | 2004-04-29 | Novogen Research Party, Ltd. | Novel therapeutic uses of glucan |
CN1235552A (zh) * | 1996-09-25 | 1999-11-17 | 格雷斯林克有限公司 | β-葡聚糖产物及从谷物中提取的方法 |
US6369216B1 (en) * | 1998-09-25 | 2002-04-09 | Biopolymer Engineering Pharmaceutical, Inc. | Very high molecular weight β-glucans |
WO2004061115A1 (ja) * | 2002-12-27 | 2004-07-22 | Immudyne Japan Inc. | 免疫機能を有する可溶性β−グルカンの製造方法及び用途 |
Also Published As
Publication number | Publication date |
---|---|
US7981447B2 (en) | 2011-07-19 |
US20090036401A1 (en) | 2009-02-05 |
CA2690918C (en) | 2016-06-28 |
KR101547970B1 (ko) | 2015-08-28 |
JP6007209B2 (ja) | 2016-10-12 |
KR20100029193A (ko) | 2010-03-16 |
CA2690918A1 (en) | 2008-11-20 |
EP2155000A1 (en) | 2010-02-24 |
JP2014198045A (ja) | 2014-10-23 |
JP2010526810A (ja) | 2010-08-05 |
AU2008251847A1 (en) | 2008-11-20 |
MX2009012070A (es) | 2009-12-08 |
BRPI0811274A2 (pt) | 2014-10-07 |
WO2008140744A1 (en) | 2008-11-20 |
MY150220A (en) | 2013-12-31 |
AU2008251847B2 (en) | 2013-09-26 |
US8530642B2 (en) | 2013-09-10 |
US20120065157A1 (en) | 2012-03-15 |
US8859759B2 (en) | 2014-10-14 |
KR20140105620A (ko) | 2014-09-01 |
CN101711112A (zh) | 2010-05-19 |
CN105310078B (zh) | 2018-03-30 |
CO6251216A2 (es) | 2011-02-21 |
CN101711112B (zh) | 2015-11-25 |
KR101665216B1 (ko) | 2016-10-11 |
JP2016198108A (ja) | 2016-12-01 |
UA101617C2 (ru) | 2013-04-25 |
US20130237497A1 (en) | 2013-09-12 |
JP5562837B2 (ja) | 2014-07-30 |
EP2155000A4 (en) | 2013-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101711112B (zh) | 粒状可溶的葡聚糖制备 | |
US4812444A (en) | Dehydration of hydrous matter using anhydrous glycosylfructose | |
US4826825A (en) | Dehydration of hydrous product using anhydrous lactitol | |
CN106387923A (zh) | 一种富含半乳甘露聚糖的可溶性膳食纤维及其制备方法 | |
Heperkan et al. | Structural analysis and properties of dextran produced by Weissella confusa and the effect of different cereals on its rheological characteristics | |
CN113278091A (zh) | 一种紫球藻多糖及其制备方法和应用 | |
US4810827A (en) | Dehydration of hydrous matter using anhydrous aldohexose | |
WO2009102008A1 (ja) | 免疫賦活作用および抗腫瘍作用を有するマイタケ由来の低分子物質 | |
CN106490614A (zh) | 一种组合物及其作为糖尿病全营养配方食品的应用 | |
CN112494347B (zh) | 一种护肤水乳及其制备方法 | |
JPH09511266A (ja) | エネルギー処方物 | |
CN106916319A (zh) | 葡聚糖接枝改性的白果蛋白制备方法及其应用 | |
CN111345418A (zh) | 一种药食同源酵素饮料及其制备方法 | |
KR20190035623A (ko) | 유해한/독성 물질의 소화 또는 흡수를 감소시키기 위한 식용 조성물 | |
JP6324551B2 (ja) | 抗乳癌剤、抗乳癌用食品、乳癌を抑制するための方法及び抗乳癌剤の製造方法 | |
CN103599079B (zh) | 注射用洛铂药物组合物及其制备方法 | |
JPWO2006126488A1 (ja) | ハナビラタケ抽出物 | |
CN106962478A (zh) | 一种肠道益生菌的保存方法 | |
Prakash et al. | A review on natural polymer locust bean gum | |
CN118388673A (zh) | 一种连续式高效提取香菇多糖的方法及其在缓解结肠炎中的应用 | |
CN114532507A (zh) | 一种凝胶果冻及其生产工艺 | |
CN118285502A (zh) | 一种水溶性良好的富含柑橘类黄酮的果粉产品制备技术与应用 | |
CN103798380B (zh) | 一种添加发菜细胞的液态奶及其制备方法 | |
JPWO2005040179A1 (ja) | ハタケシメジ子実体由来組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |